CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Find which retirement index fund has the best fee and how this impacts your overall returns. Learn to spot the true cost leaders.
28,127 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A single indicator could steer the next 12 months for the iShares 20+ Year Treasury Bond ETF (TLT). If the 30-year yi...
When a major concert switches venues, fans face more than changed plans. Sting’s Tampa concert moves to Orlando, but ...
Dive into a practical look at how Kleiner Perkins evaluates AI startups, drawn from the transcript: mamoon hamid, kle...
Zircuit Finance unveils an institutional-grade on-chain yield vault designed to deliver 8-11% APR, combining cross-ch...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
Tourist crowds driven by social media push up prices and squeeze housing in popular spots. This report tracks how ove...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
A high-quality, short-duration AAA CLO ETF is drawing attention by offering more income than 3-month Treasuries. For ...
Apple and Nvidia sit at the pinnacle of market caps, but they play very different roles in investors’ portfolios. Thi...
Arizona Senate Finance Committee advances a bill that could place XRP and DigiByte in a state Digital Assets Strategi...